We showed that genes ANLN, CDK1, ECT2, and TNC were associated with adenoma progression to carcinoma, ANLN and PDGFD with development of metastases, while genes ANLN, CDK1, ECT2, and PDGFD were associated with the level of malignancy. This evidence concerns the gene ANLN and carcinoma.